Arteris Appoints New Director David L. Simon

Ticker: AIP · Form: 8-K · Filed: 2025-03-28T00:00:00.000Z

Sentiment: neutral

Topics: board-appointment, governance

TL;DR

Arteris adds semiconductor vet David L. Simon to its board, effective 3/25/25.

AI Summary

Arteris, Inc. announced on March 25, 2025, the appointment of David L. Simon as a new director to its Board of Directors. Simon, who has extensive experience in the semiconductor industry, will serve on the Audit Committee and the Compensation Committee. This appointment is effective immediately.

Why It Matters

The addition of an experienced director like David L. Simon to Arteris's board could bring valuable strategic insights and governance oversight, potentially impacting the company's future direction and investor confidence.

Risk Assessment

Risk Level: low — This filing is a routine corporate governance update regarding a board appointment and does not involve significant financial transactions or operational changes.

Key Players & Entities

FAQ

Who is David L. Simon and what is his background?

The filing does not provide specific details about David L. Simon's background beyond his appointment as a director and his committee assignments. Further information would typically be found in a more detailed press release or proxy statement.

When was David L. Simon appointed to the board?

David L. Simon was appointed to the Board of Directors effective March 25, 2025.

Which committees will David L. Simon serve on?

David L. Simon will serve on the Audit Committee and the Compensation Committee.

What is the significance of this board appointment for Arteris, Inc.?

The filing states this is an appointment of a director, which is a standard corporate governance action. The specific impact is not detailed in this 8-K, but typically such appointments aim to strengthen board expertise.

Are there any financial implications mentioned in this filing regarding the new director?

This filing does not mention any specific financial implications or compensation details for David L. Simon in relation to his appointment as a director.

From the Filing

0001193125-25-066596.txt : 20250328 0001193125-25-066596.hdr.sgml : 20250328 20250328121227 ACCESSION NUMBER: 0001193125-25-066596 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250325 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250328 DATE AS OF CHANGE: 20250328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arteris, Inc. CENTRAL INDEX KEY: 0001667011 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40960 FILM NUMBER: 25783304 BUSINESS ADDRESS: STREET 1: 900 E. HAMILTON AVE, SUITE 300 CITY: CAMPBELL STATE: CA ZIP: 95008 BUSINESS PHONE: (408) 470-7300 MAIL ADDRESS: STREET 1: 900 E. HAMILTON AVE, SUITE 300 CITY: CAMPBELL STATE: CA ZIP: 95008 8-K 1 d743344d8k.htm 8-K 8-K false 0001667011 0001667011 2025-03-25 2025-03-25     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2025     ARTERIS, INC. (Exact name of registrant as specified in its charter)       Delaware   001-40960   27-0117058 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification Number)   900 E. Hamilton Avenue Suite 300 Campbell , CA   95008 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (408) 470-7300 Former name or former address, if changed since last report: N/A     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.001 par value per share   AIP   The Nasdaq Stock Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐       Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 25, 2025, Isabelle F. Geday notified the board of directors (the “Board”) of Arteris, Inc. (the “Company”) of her decision to resign from the Board, effective as of March 27, 2025. Ms. Geday’s decision to resign from the Board was for personal reasons and not due to any disagreements with the Company relating to the Company’s operations, policies or practices.

View on Read The Filing